UK Environmental Risk Assessment Requirements for Human Medicinal Products
Environmental Risk Assessment (ERA) is an important consideration when applying for marketing authorisation for human medicinal products in the United Kingdom. Pharmaceutical substances may enter the environment through patient use, manufacturing activities and disposal.
Pharmaceutical Labeling Compliance: A Complete Guide for Regulatory Affairs Teams
Pharmaceutical labeling compliance ensures that information provided on pharmaceutical product labels is accurate, consistent, and aligned with applicable regulatory requirements. Product labeling plays an important role in communicating essential information to healthcare professionals, patients, and other stakeholders. It includes details such as product composition, dosage instructions, indications, contraindications, warnings, storage conditions, and manufacturer information. Maintaining accurate labeling helps pharmaceutical companies support patient safety and ensure that medicines are used appropriately.Medical Device Regulatory Affairs: A Complete Guide for Manufacturers in 2026
Device regulatory affairs is essential for making sure that medical devices are safe high quality and perform well before they enter markets around the world. In the year 2026 manufacturers must deal with changing rules, international guidelines and expectations for compliance in order to launch and keep their products available in many regions.
Occupational Exposure Limit (OEL): Complete Guide for Pharmaceutical Industries
An Occupational exposure limit (OEL) defines the maximum acceptable concentration of a chemical or pharmaceutical substance that workers can be exposed to during workplace activities.